Novogene Statistics

Total Valuation

Novogene has a market cap or net worth of CNY 5.88 billion. The enterprise value is 4.35 billion.

Market Cap	5.88B
Enterprise Value	4.35B

Important Dates

The last earnings date was Wednesday, April 15, 2026.

Earnings Date	Apr 15, 2026
Ex-Dividend Date	Jun 10, 2025

Share Statistics

Novogene has 405.06 million shares outstanding. The number of shares has decreased by -2.82% in one year.

Current Share Class	405.06M
Shares Outstanding	405.06M
Shares Change (YoY)	-2.82%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	53.05%
Owned by Institutions (%)	9.90%
Float	136.65M

Valuation Ratios

The trailing PE ratio is 36.32 and the forward PE ratio is 28.19.

PE Ratio	36.32
Forward PE	28.19
PS Ratio	2.60
PB Ratio	2.17
P/TBV Ratio	2.22
P/FCF Ratio	44.57
P/OCF Ratio	23.82
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.82, with an EV/FCF ratio of 32.97.

EV / Earnings	26.77
EV / Sales	1.92
EV / EBITDA	14.82
EV / EBIT	28.17
EV / FCF	32.97

Financial Position

The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.03.

Current Ratio	2.62
Quick Ratio	2.16
Debt / Equity	0.03
Debt / EBITDA	0.23
Debt / FCF	0.52
Interest Coverage	76.42

Financial Efficiency

Return on equity (ROE) is 6.36% and return on invested capital (ROIC) is 12.61%.

Return on Equity (ROE)	6.36%
Return on Assets (ROA)	2.58%
Return on Invested Capital (ROIC)	12.61%
Return on Capital Employed (ROCE)	5.60%
Weighted Average Cost of Capital (WACC)	8.56%
Revenue Per Employee	1.03M
Profits Per Employee	73,807
Employee Count	2,190
Asset Turnover	0.61
Inventory Turnover	5.06

Taxes

In the past 12 months, Novogene has paid 24.87 million in taxes.

Income Tax	24.87M
Effective Tax Rate	12.93%

Stock Price Statistics

The stock price has increased by +5.37% in the last 52 weeks. The beta is 0.80, so Novogene's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+5.37%
50-Day Moving Average	14.40
200-Day Moving Average	14.89
Relative Strength Index (RSI)	53.16
Average Volume (20 Days)	3,072,039

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novogene had revenue of CNY 2.26 billion and earned 162.52 million in profits. Earnings per share was 0.40.

Revenue	2.26B
Gross Profit	972.50M
Operating Income	154.45M
Pretax Income	192.33M
Net Income	162.52M
EBITDA	272.97M
EBIT	154.45M
Earnings Per Share (EPS)	0.40

Full Income Statement

Balance Sheet

The company has 1.63 billion in cash and 68.62 million in debt, giving a net cash position of 1.56 billion or 3.85 per share.

Cash & Cash Equivalents	1.63B
Total Debt	68.62M
Net Cash	1.56B
Net Cash Per Share	3.85
Equity (Book Value)	2.71B
Book Value Per Share	6.61
Working Capital	1.74B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 246.90 million and capital expenditures -114.94 million, giving a free cash flow of 131.96 million.

Operating Cash Flow	246.90M
Capital Expenditures	-114.94M
Depreciation & Amortization	118.52M
Net Borrowing	-17.02M
Free Cash Flow	131.96M
FCF Per Share	0.33

Full Cash Flow Statement

Margins

Gross margin is 42.95%, with operating and profit margins of 6.82% and 7.18%.

Gross Margin	42.95%
Operating Margin	6.82%
Pretax Margin	8.49%
Profit Margin	7.18%
EBITDA Margin	12.06%
EBIT Margin	6.82%
FCF Margin	5.83%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.31%.

Dividend Per Share	0.05
Dividend Yield	0.31%
Dividend Growth (YoY)	5.26%
Years of Dividend Growth	2
Payout Ratio	12.46%
Buyback Yield	2.82%
Shareholder Yield	3.12%
Earnings Yield	2.76%
FCF Yield	2.24%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novogene has an Altman Z-Score of 4.88 and a Piotroski F-Score of 6.

Altman Z-Score	4.88
Piotroski F-Score	6